CARDIOVASCULAR REACTIONS AND RESPIRATORY EVENTS DURING PLATELET ACTIVATING FACTOR-INDUCED SHOCK

被引:13
作者
FELIX, SB
BAUMANN, G
RASCHKE, P
MAUS, C
BERDEL, WE
机构
[1] I. Medizinische Klinik, Klinikum rechts der Isar, Technische Universität München, München 80, 8000
关键词
cardiovascular shock; coronary vasospasm; platelet activating factor; respiratory distress; ventricular contractile failure;
D O I
10.1007/BF01907110
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The platelet activating factor (PAF), a low molecular phospholipid, plays an important role in inflammation, anaphylaxis, and shock state development. In the isolated perfused guinea pig heart, PAF induces a decrease in coronary flow and cardiac contractility and atrioventricular conduction disturbances. Furthermore, PAF mediates a powerful bronchoconstrictory action causing a severe impairment in respiratory function. In the present study an attempt was made to separate cardiac from respiratory events during PAF-induced shock in vivo. PAF was injected intravenously (0.1-10 μg/kg) into anesthetized guinea pigs ventilated with room air or 100% oxygen. Administration of 10 μg/kg PAF was uniformly lethal: already within 2 min, cardiac output decreased by 60% and end-diastolic left ventricular pressure increased markedly indicating cardiac failure. ECG recordings showed signs of acute myocardial ischemia. Arrhythmias occurred in terms of atrioventricular conduction delay. Blood pressure initially increased, then declined continuously to below baseline within 10 min. All animals died within 25 min. Ventilation with room air was paralleled by development of severe hypoxia. However, under ventilation with 100% oxygen a dissociation between PAF-mediated cardiac and respiratory effects occurred. It is concluded that the PAF-induced shock is primarily based on direct cardiac damage. Furthermore, the ECG signs of ischemia are most likely due to coronary spasms. © 1990 Dr. Dietrich Steinkopff Verlag.
引用
收藏
页码:217 / 226
页数:10
相关论文
共 27 条
[1]  
BENVENISTE J, 1979, CR ACAD SCI D NAT, V289, P1037
[2]  
BENVENISTE J, 1972, J EXP MED, V136, P1536
[3]   ACUTE CIRCULATORY COLLAPSE CAUSED BY PLATELET-ACTIVATING FACTOR (PAF-ACETHER) IN DOGS [J].
BESSIN, P ;
BONNET, J ;
APFFEL, D ;
SOULARD, C ;
DESGROUX, L ;
PELAS, I ;
BENVENISTE, J .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1983, 86 (3-4) :403-413
[4]   ACUTE MICROVASCULAR EFFECTS OF PAF-ACETHER, AS STUDIED BY INTRAVITAL MICROSCOPY [J].
BJORK, J ;
SMEDEGARD, G .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1983, 96 (1-2) :87-94
[5]   ANTIHYPERTENSIVE ACTIVITY OF AN ALKYL ETHER ANALOG OF PHOSPHATIDYLCHOLINE [J].
BLANK, ML ;
SNYDER, F ;
BYERS, LW ;
BROOKS, B ;
MUIRHEAD, EE .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1979, 90 (04) :1194-1200
[6]   THE ROLE OF PAF IN IMMUNOLOGICAL RESPONSES - A REVIEW [J].
BRAQUET, P ;
ROLAPLESZCZYNSKI, M .
PROSTAGLANDINS, 1987, 34 (02) :143-147
[7]  
CAMUSSI G, 1981, IMMUNOLOGY, V42, P191
[8]  
Camussi Giovanni, 1987, PLATELET ACTIVATING, P299
[9]   ROLE OF PLATELET-ACTIVATING FACTOR IN PLATELET-AGGREGATION [J].
CHIGNARD, M ;
LECOUEDIC, JP ;
TENCE, M ;
VARGAFTIG, BB ;
BENVENISTE, J .
NATURE, 1979, 279 (5716) :799-800
[10]   EVIDENCE OF A ROLE FOR PAF-ACETHER IN THE PATHOPHYSIOLOGY OF THE SHOCK STATE [J].
CRESPO, MS ;
INARREA, P ;
NIETO, ML ;
FERNANDEZGALLARDO, S .
PHARMACOLOGICAL RESEARCH COMMUNICATIONS, 1986, 18 :181-196